ASP5834

ASP5834 · Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP5834, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors [Phase 1]